Anand Patel, MD, is board-certified hematologist-oncologist and an expert in treating myeloproliferative diseases, myelodysplastic syndromes and leukemia. In addition to providing his patients with standard treatment approaches such as chemotherapy and targeted therapies, Dr. Patel is also committed to delivering novel therapies through clinical trials that combine basic and translational research into groundbreaking advancements in medicine for better outcomes and quality of life.

Dr. Patel’s research interests are geared towards the development of clinical trials that help improve the standard of care for patients with high-risk leukemias and myeloid malignancies. His research has been published in several peer-reviewed journals, such as Blood Advances, British Journal of Haematology, Cancer, JCI Insight and Bone Marrow Transplantation.